Trends of a burden on atherosclerotic cardiovascular disease and its related risk factors in China, 1990 to 2019
10.3760/cma.j.cn112338-20201208-01390
- VernacularTitle:1990-2019年中国动脉粥样硬化心血管病疾病负担变化及其危险因素分析
- Author:
Mengni ZHANG
1
;
Maoting LI
;
Xinyue ZHI
;
Hong ZHU
;
Xin ZHANG
;
Juan XIE
Author Information
1. 天津医科大学公共卫生学院/天津市环境营养与人群健康重点实验室/环境营养与人群健康国际联合研究中心 300070
- Keywords:
Atherosclerotic cardiovascular disease;
Burden of disease;
Population aging;
Risk factors
- From:
Chinese Journal of Epidemiology
2021;42(10):1797-1803
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To quantitatively analyze the effects of population aging and other risk factors on the burden of atherosclerosis cardiovascular disease (ASCVD) in China from 1990 to 2019.Methods:Disability adjusted life years (DALY) and age-standardized rates obtained from the Global Burden of Disease Study 2019 (GBD2019) were used to describe the temporal trend of a burden on ASCVD. And a decomposition method established by Gupta was applied to quantify the burden related to population growth, aging, age-specific prevalence, and the severity of the disease.Results:In 2019, 61.00% of the burden of cardiovascular disease in China was caused by ASCVD. The DALY of ischemic heart disease increased by 133.66% compared with that in 1990, with 29.57% of the increase attributed to population growth, 108.74% due to population aging, and 8.87% due to the rise of age-specific prevalence and -13.53% benefited from changes in disease severity. The DALY of ischemic stroke increased by 138.64% compared with 1990, and the proportions attributable to the above four parts were 30.95%, 123.38%, 55.80%, and -71.49%, respectively. Hypertension remained the leading risk factor for ASCVD in 2019, followed by high LDL cholesterol. The age-standardized DALY rate attributable to drinking had the most significant increase (486.01%) from 1990, with an average annual growth of 10.93%.Conclusions:Aging population seems responsible for the main reason for the considerable increase in the burden of ASCVD in China. Still, the adverse trends of other avoidable risk factors, especially metabolic risk factors, can not be ignored.
